Future studies employing genetic and pharmacologic approaches in mouse models of PN will be an invaluable tool to demonstrate necessity of this NRX1-NLGN1 pathway as a critical determinant of this disease. Here, NLGN1 is linked to poikiloderma with neutropenia.